Changeflow GovPing Healthcare & Life Sciences Omega 3 Basix Trademark Published for Opposition
Routine Notice Added Final

Omega 3 Basix Trademark Published for Opposition

Favicon for changeflow.com USPTO Trademarks - Pharmaceuticals (Class 005)
Published
Detected
Email

Summary

The USPTO has published the trademark application for 'Omega 3 Basix' for opposition, with a publication date of March 22, 2026. The application covers dietary and nutritional supplements, including those containing enzymatically enhanced monoglyceride fish oils.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application for 'Omega 3 Basix' (TM99492264) for opposition. This publication signifies that the application has passed initial examination and is now open to challenges from third parties for a statutory period. The goods listed include dietary and nutritional supplements, specifically those formulated with enzymatically enhanced monoglyceride fish oils for essential omega-3 fatty acids.

For entities involved in the dietary supplement market, this publication is a notice of a new trademark potentially entering the space. While this is not a final registration, it is a significant step in the trademark process. Companies should monitor the opposition period, which begins on the publication date, to identify any potential conflicts with their own existing trademarks or brands. No immediate compliance actions are required for most entities, but legal counsel should be consulted if there is a perceived conflict.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

OMEGA 3 BASIX

Published for Opposition TM99492264 Kind: published Mar 22, 2026

Abstract

Dietary and nutritional supplements containing enzymatically enhanced monoglyceride fish oils providing essential omega-3 fatty acids to support overall health; Specifically formulated, prepared, and packaged dietary and nutritional supplements; dietary food supplements; dietary supplements

Filing Date

2025-11-12

View original document →

Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 22nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM99492264

Who this affects

Applies to
Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Consumer Health Food and Beverage

Get alerts for this source

We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!